Live Breaking News & Updates on Immune Modulators

Stay updated with breaking news from Immune modulators. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Synthekine Presents Preclinical Data at SITC 38th Annual Meeting Demonstrating its IL-12 Partial Agonist, STK-026, Significantly Expands Therapeutic Window

Synthekine Presents Preclinical Data at SITC 38th Annual Meeting Demonstrating its IL-12 Partial Agonist, STK-026, Significantly Expands Therapeutic Window
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Synthekine Inc , Society For Immunotherapy Of Cancer , Annual Meeting , Martin Oft , Preclinical Pharmacodynamic Characterization , Improved Therapeutic Window , Immune Modulators , Board Number , Key Findings ,

Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia

ELK CITY, Idaho, September 11, 2023 Therapeutic Solutions International, Inc. (TSOI), announced today the development of a new therapeutic approach for treatment of Frontotemporal Dementia, by combining the activation of endogenous anti-inflammatory cells in the nervous system, together with regenerative cell intervention in the form of stem cell therapy, and molecules capable of activating endogenous stem cells already present in the patient. ....

United States , Timothyg Dixon , Thomas Ichim , Campbell Neurosciences , James Veltmeyer , Therapeutic Solutions International , Company Leverages , Board Member Of The Company , Veltmeyer Institute , Therapeutic Solutions International Inc , New Drug Disease Filing , Clinical Experiences Under Right , Create Multidisciplinary Protocol , Address Common , Frontotemporal Dementia , Chief Medical Officer , Board Member , Solutions International , Chief Executive Officer , Frontotemporal Dementia , The Company , Therapeutic Solutions International , Stem Cell Therapy , Therapeutic Solutions , Dr James Veltmeyer , Chief Medical Officer ,